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Stress and anxiety play an important role in the development and maintenance of drug and
alcohol addiction. The bed nucleus of the stria terminalis (BNST), a brain region involved in
the production of long-term stress-related behaviors, plays an important role in animal mod-
els of relapse, such as reinstatement to previously extinguished drug-seeking behaviors.
While a number of neurotransmitter systems have been suggested to play a role in these
behaviors, recent evidence points to the neuropeptide corticotropin releasing factor (CRF)
as being critically important in BNST-mediated reinstatement behaviors. Although numer-
ous studies indicate that the BNST is a complex brain region with multiple afferent and
efferent systems and a variety of cell types, there has only been limited work to determine
how CRF modulates this complex neuronal system at the circuit level. Recent work from
our lab and others have begun to unravel these BNST neurocircuits and explore their roles
in CRF-related reinstatement behaviors. This review will examine the role of CRF signaling
in drug addiction and reinstatement with an emphasis on critical neurocircuitry within the
BNST that may offer new insights into treatments for addiction.
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INTRODUCTION
Alcohol and drug addiction are chronically relapsing disorders in
which alcohol/drug use progresses from initial stages of limited,
non-dependent intake to later stages of uncontrolled abuse (Koob,
2009; Koob and Volkow, 2010). One prominent theory posits that
initial periods of use are driven primarily by the positive rein-
forcing value of drugs and alcohol (euphoria) while later stages
of alcohol/drug addiction are driven by negative reinforcement
(relief of withdrawal-induced negative affective states) (Koob and
Volkow, 2010). The primary reinforcing effects of alcohol and
other drugs are thought to occur by increased dopamine (DA)
signaling that leads to enhanced activity of the mesocorticolim-
bic pathway, which in turn likely leads to escalated craving (Wise,
1980; Di Chiara and Imperato, 1988; Di Chiara, 2002; Volkow
et al., 2003). Escalated alcohol/drug taking and prolonged binge
episodes are thought to result in adaptation to the mesocorti-
colimbic pathway that results in devaluation of natural rewards,
diminished cognitive control of behaviors, and increased salience
of drug-related stimuli (Koob and Le, 2001; Koob and Volkow,
2010). During this time, the dorsal striatum, which typically plays
a limited role in the acute reinforcing effects of drugs, becomes
engaged after prolonged drug exposures and promotes compul-
sive drug-seeking typical in addiction (Everitt et al., 2008). For
more complete reviews of mesocorticolimbic function in the ini-
tiation of drug addiction refer to (Feltenstein and See, 2008; Koob
and Volkow, 2010).
Stressors and negative affective states, such as anxiety and
depression, are often cited by recovering addicts as key instigators
of drug craving and relapse (Sinha, 2007). Drug/alcohol binges are
typically followed by various lengths of drug-withdrawal periods
and numerous studies have shown that repeated binge/withdrawal
episodes can recruit and sensitize brain regions associated with
negative affective states, such as those that comprise the extended
amygdala (for review see Koob, 2008; Koob and Volkow, 2010).
Once recruited during withdrawal, brain regions associated with
negative affect can remain hypersensitive even after extended
periods of abstinence (Santucci et al., 2008). Furthermore, relief
of negative emotional states is thought to be a critical compo-
nent of alcohol/drug seeking during withdrawal (Koob, 2009).
This suggests that brain regions associated with stress reactivity
and negative affect, particularly the extended amygdala, become
hypersensitive following repeated binge/withdrawal cycles and
may mediate the transition to long-term addictive behaviors via
negative reinforcement.
Altogether, these ideas support an important role of stress-
related neurocircuitry in the progression of addiction and in
relapse. Clinical studies on relapse have been paralleled and
now extended in preclinical studies utilizing reinstatement mod-
els (Shaham et al., 2003). In this manuscript, we will review
recent findings on the neurocircuitry of drug-seeking behaviors
with a specific focus on those systems involved in enhanced
drug-seeking during stress-induced relapse. We will also high-
light potential mechanisms by which stress-related neurocir-
cuitry may modulate drug-seeking behaviors that could be
used for potential treatment targets for alcoholism and drug
addiction.
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NEUROCIRCUITRY INVOLVED IN DRUG SEEKING DURING
WITHDRAWAL AND REINSTATEMENT
Reinstatement models typically involve training an animal to
work to receive a drug or alcohol for a given period of time,
then extinguishing that behavior before triggering the animal
to seek out drugs again (Shaham et al., 2003; Epstein et al.,
2006). Typical triggers of reinstatement are (1) re-exposure
to the same or related drug previously administered (drug-
induced reinstatement), (2) giving the animal drug-associated
stimuli or cues (cue-induced reinstatement), or (3) exposure
to a variety of stressors (stress-induced reinstatement). Work
from reinstatement models has shown distinct roles of multi-
ple brain regions and neurotransmitter systems in each type of
reinstatement.
NEUROCIRCUITRY OF DRUG-INDUCED REINSTATEMENT
A great deal of research has shown that increased activity of brain
regions projecting to the mesocortical DA system is a critical
factor in drug-induced reinstatement models (for review see Kali-
vas and Volkow, 2005; Feltenstein and See, 2008). One pathway
shown to be critical to drug-induced reinstatement is a glutamater-
gic projection from the medial prefrontal cortex to the nucleus
accumbens (Stewart and Vezina, 1988; Cornish and Kalivas, 2000;
McFarland and Kalivas, 2001). Furthermore, limbic areas like
the basolateral amygdala (BLA) may play a role in drug-induced
reinstatement by enhanced activity of its glutamatergic projec-
tions to mesocorticolimbic system (McFarland and Kalivas, 2001;
Fuchs and See, 2002). Therefore drug-induced reinstatement likely
occurs via increased glutamatergic transmission to enhance meso-
corticolimbic pathway activity, likely from cortical and limbic
areas as well as by direct action of the drug of abuse on meso-
corticolimbic DA receptors (for review see, Feltenstein and See,
2008).
NEUROCIRCUITRY OF CUE-INDUCED REINSTATEMENT
In addition to its role in drug-induced reinstatement, numer-
ous studies have shown an important role for the BLA in
cue-induced reinstatement. Exposure to drug-associated cues
results in increased DA release and increased c-fos activa-
tion in the BLA following withdrawal (Neisewander et al.,
1998; Weiss et al., 2000). Furthermore, intra-BLA injections
of DA receptor antagonists block cue-induced reinstatement
(See et al., 2001). Stimulation of the BLA has been shown
to increase DA efflux in the nucleus accumbens via a glu-
tamate receptor-dependent mechanism (Howland et al., 2002)
suggesting an important role of glutamatergic afferents to the
mesolimbic DA system in cue-induced reinstatement. The medial
prefrontal cortex (Van den Oever et al., 2010) and the cen-
tral nucleus of the amygdala (Radwanska et al., 2008) have
also been shown to be important in cue-induced reinstate-
ment.
Overall, these findings suggest that DA or glutamatergic neu-
rotransmission in the mesocorticolimbic pathway or its affer-
ents could be targets for therapies to reduce relapse in recover-
ing addicts. However, use of dopaminergic agonists has yet to
be proven effective for long-term relapse treatment (Lingford-
Hughes et al., 2010) and may be problematic in regards to abuse
liability (Shorter and Kosten, 2011). In addition, therapeutics tar-
geting DA receptors may be problematic because of potential side
effects due to interactions with motor systems or interactions with
the cardiovascular system since modulating DA receptor activity
can have effects on hemodynamics and cardiovascular function
(Zeng et al., 2007; Banday and Lokhandwala, 2008). Furthermore,
drugs targeting glutamatergic transmission given orally may also
cause problematic side-effects as modulating glutamate receptors
can adversely affect many other brain regions not involved in rein-
statement. These findings leave the field open to the need of more
selective DA or glutamatergic drugs or drugs targeting different
receptor systems.
EXTENDED AMYGDALA NEUROCIRCUITRY IN STRESS-INDUCED
REINSTATEMENT
Stress-induced reinstatement may be a critical model for find-
ing suitable therapeutic targets for two important reasons. First,
recovering addicts can work to modify their behavior to avoid drug
re-exposure and exposure to drug-related cues as often as possible
while stress in daily human life is virtually inevitable. Situations
like family issues, finding and maintaining work, and even traffic
in daily commutes can be stressful events to any person and may
be sensitized in recovering addicts. Therefore, it is not surprising
that stress is a major trigger for relapse in addicted patients (Sinha,
2007) and may make therapies targeting this system more likely
to be effective in preventing relapse. Second, the neuromodula-
tory systems involved in stress-induced reinstatement described
below may make for better pharmacotherapeutic targets due to
their limited abuse liability and potentially less significant side
effect profiles.
A great deal of work has examined stress-induced relapse in the
preclinical setting, and a variety of stressors have been shown to
reinstate drug-seeking behaviors or preference. These include foot-
shock, restraint stress, and forced swim stress (Shaham et al., 2003;
Tzschentke, 2007; Shalev et al., 2010). These studies have revealed
key neurobiological mechanisms of stress-induced reinstatement,
with a particular focus on the effects of two stress-related neu-
romodulatory systems, norepinephrine (NE) and corticotropin
releasing factor (CRF), in two related brain regions of the extended
amygdala, the central nucleus of the amygdala and bed nucleus of
the stria terminalis (BNST) (Shaham et al., 2003; Epstein et al.,
2006; Sofuoglu and Sewell, 2009; Erb, 2010; Haass-Koffler and
Bartlett, 2012).
Withdrawal from chronic drug abuse can lead to NE dysfunc-
tion in the clinical population that is associated with increased vul-
nerability to anxiety (McDougle et al., 1994). Numerous preclini-
cal studies have also shown drug-withdrawal-induced increases in
anxiety-like behaviors and withdrawal-induced escalation in drug
intake can be ameliorated by blockade of β- and α1-adrenergic
receptors (ARs) (Rudoy and Van Bockstaele, 2007; Wee et al., 2008;
Rudoy et al., 2009; Forget et al., 2010; Verplaetse et al., 2012).
Importantly, ICV injection of NE increases fos expression in the
BNST (Brown et al., 2011) and β-AR antagonists microinjected
into the extended amygdala can block stress-induced reinstate-
ment (Leri et al., 2002) suggesting that dysfunction of NE sys-
tems in the extended amygdala is likely a key factor in enhanced
drug-seeking following stress.
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CENTRAL AMYGDALA NEUROCIRCUITRY IN ADDICTION
The central amygdala (CeA) appears to contribute to the use
of a number of different drugs. Acute and chronic alcohol/drug
exposures and withdrawal increase CRF biosynthesis in the CeA
(Merlo et al., 1995; Rodriguez de et al., 1997; Richter and Weiss,
1999; Maj et al., 2003; George et al., 2007; Zorrilla et al., 2012)
and the CeA sends a CRF-containing projection to the BNST
that is critical for stress-induced reinstatement (Erb et al., 2001).
Therefore, an understanding of drug/alcohol interactions with
CeA CRF neurocircuitry may provide an insight into an impor-
tant interface between stress and addiction A series of studies
have shown that EtOH enhances GABAergic neurotransmission
in the CeA via a CRF type 1 receptor (CRFR1)-dependent mech-
anism (Roberto et al., 2003, 2010; Nie et al., 2009). Mice exposed
to chronic intermittent ethanol (CIE) exhibit higher levels of
EtOH drinking, increased GABA release, and heightened CeA
CRFR1 sensitivity during withdrawal, suggesting a key role of
CRF-GABA interaction in the CeA in the development of EtOH
dependence (Roberto et al., 2004, 2010). Furthermore, treating
mice with CRFR1 antagonists blocked the ability of CIE to increase
alcohol drinking (Roberto et al., 2010). CIE-induced increases
in alcohol self-administration are also blocked by an intra-CeA
microinjection of a non-selective CRFR antagonist (Funk et al.,
2006a). CeA CRF neurocircuitry is also activated during binge-like
EtOH self-administration prior to the development of depen-
dence and binge-like EtOH consumption can be reduced by intra-
CeA microinjections of CRFR1 antagonists (Lowery-Gionta et al.,
2012). Since CRFR1 antagonists can block stress-induced increases
in EtOH self-administration (Hansson et al., 2006; Marinelli et al.,
2007; Lowery et al., 2008), these findings indicate that changes in
CeA CRF signaling may play an important role in the development
and maintenance of EtOH addiction and in relapse.
In addition to its effects on CeA GABAergic neurotransmission
and its functional role in EtOH induced alterations to CeA activity,
CRFR1 can also enhance CeA glutamatergic neurotransmission.
CRFR1 activation increases glutamate release from specific presy-
naptic sources in the CeA (Liu et al., 2004; Silberman and Winder,
2013) and can induce long-term potentiation of the BLA-CeA
pathway (Fu et al., 2007). This effect can be manipulated by
chronic drug exposures as withdrawal from chronic intermittent
cocaine can enhance CRFR1 induced long-term potentiation of
CeA synaptic transmission (Fu et al., 2007), suggesting that CeA
CRF signaling is important for cocaine related behaviors and may
play an important role in the development of cocaine addiction.
Blockade of CeA CRFR1 can also attenuate dysphoria associated
with nicotine withdrawal (Bruijnzeel et al., 2012). These findings
suggest that changes in CeA CRF neurotransmission may play
a role in addiction to multiple drug types. However, although
CRF-producing neurons do exist in the CeA, it is not yet clear
if these neurons are the source of extracellular CRF in the CeA
as our recent studies suggests that CRF neurons in the CeA may
be predominantly projection type (Silberman et al., 2013). Indeed,
some evidence indicates that other brain regions may be the major
source of extracellular CRF in the CeA (Uryu et al., 1992). It is also
not yet clear how alcohol/drugs might alter the activity of CeA CRF
neurons that project to the BNST. Future research will be needed
to determine how CeA CRF signaling to the BNST is altered by
chronic alcohol or drug exposure that may make them more sen-
sitive to stress to promote CRF release in the BNST to initiate
reinstatement.
BED NUCLEUS OF THE STRIA TERMINALIS NEUROCIRCUITRY IN
STRESS-INDUCED REINSTATEMENT
Alcohol and other drugs of abuse can also modulate CRF activity in
the BNST. Protracted withdrawal from cocaine, heroin, and alco-
hol can result in a dysregulation of the intrinsic excitability of some
BNST neurons via a CRF-mediated mechanism (Francesconi et al.,
2009), suggesting that repeated activation of BNST CRF receptors
likely plays a critical role in the development of drug-withdrawal
symptomology. Furthermore, microinjections of CRFR1 antag-
onists into the BNST can block stress-induced reinstatement of
drug-seeking (Erb and Stewart, 1999; Erb et al., 2001) while
microinjections of CRF into the BNST can drive reinstatement
for drug-seeking (Erb and Stewart, 1999). Together, these findings
suggest that CRFR1 within the BNST is a critical component of
stress-induced reinstatement behaviors.
While the above studies have shown a clear role of BNST CRF
signaling in stress-induced reinstatement of cocaine seeking, it
less clear what role CRF signaling in the BNST plays in alcohol
addiction. For instance, although intra-CeA injections of CRF
antagonists post CIE can block CIE-induced increases in EtOH
self-administration, post-CIE intra-BNST injections of the same
antagonist does not block enhanced drinking (Funk et al., 2006a).
However, a series of studies indicate that BNST CRF signaling
becomes enhanced during exposure to stressors that elicit rein-
statement to ethanol seeking (Le et al., 2000; Funk et al., 2006b).
Interestingly, cycles of stressors can substitute for cycles of inter-
mittent EtOH exposures to increase withdrawal-induced anxiety,
an effect that is also CRF receptor dependent (Breese et al., 2004).
Furthermore, recent studies indicate that intra-BNST injections
of CRF before ethanol exposure sensitized ethanol-withdrawal-
induced anxiety while intra-BNST CRFR1 antagonist injections
prior to stress blocked increases of anxiety-like behavior during
ethanol withdrawal (Huang et al., 2010). Therefore, it is likely
that the combination of repeated EtOH exposure and stressors
(environmental stress or drug-withdrawal stress) sensitizes BNST
CRF activity to promote anxiety-like behaviors in withdrawal.
This sensitized BNST CRF activity may increase the likelihood of
stress-induced reinstatement of ethanol and other drugs of abuse.
MECHANISMS OF NE/CRF INTERACTIONS IN
STRESS-INDUCED REINSTATEMENT
Together, the findings reviewed above indicate that both NE and
CRF in the extended amygdala are key components of both acute
drug-withdrawal syndromes and reinstatement. Although we now
have a better understanding of the neurocircuitry and neuro-
transmitter systems involved in stress-induced reinstatement, it is
still unclear how chronic exposure to drugs modulates NE/CRF-
related neurocircuitry in the extended amygdala to sensitize stress
pathways and precipitate reinstatement. For these reasons, our
lab and others have recently focused on this neurocircuitry to
elucidate the major neuronal mechanisms involved in enhanced
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stress sensitivity following chronic drug exposure and role of this
circuitry in the addiction process.
NE/CRF INTERACTIONS IN THE BNST PROMOTE REINSTATEMENT TO
DRUG SEEKING
While the work described in the previous section indicates an
important role of NE and CRF signaling in modulation of BNST
activity in stress-induced reinstatement behaviors, the mecha-
nisms by which stress-related signaling modulates extended amyg-
dala activity and how this modulated activity drives alcohol/drug
seeking is not well understood. One clue as to the mechanism of
BNST NE and CRF signaling is that pretreatment with a CRFR
antagonist can block reinstating effects of AR stimulation while
blockade of adrenergic signaling does not alter CRF-induced rein-
statement (Brown et al., 2009). Given the likely role of β-AR
receptors in the BNST in stress-induced reinstatement (Leri et al.,
2002), these findings suggests that β-AR and CRF systems may
interact in the BNST to initiate drug-seeking behavior following
stress exposure and that β-ARs and CRFRs may work in a serial
fashion to enhance BNST activity. To confirm this mechanism,
our lab examined the role of β-ARs and CRFRs on glutamatergic
transmission in the BNST (Nobis et al., 2011). In these studies, the
β-AR agonist, isoproterenol, and CRF increased the frequency of
spontaneous glutamatergic neurotransmission in the BNST. Inter-
estingly, the effect of both drugs was blocked by pretreatment with
a CRFR1 antagonist. The effects of CRF and isoproterenol were
occluded during acute withdrawal from chronic cocaine exposure,
suggesting that serial NE-CRF signaling in the BNST is engaged
in vivo during drug exposures (Nobis et al., 2011).
POTENTIAL ROLE FOR CRF-PRODUCING NEURONSWITHIN THE BNST
IN STRESS-INDUCED REINSTATEMENT
While it has been established that elevated CRF levels in the BNST
are important for stress-induced reinstatement, one remaining
question is the source of elevated extracellular CRF in the BNST
in response to stress exposure. CRF could be released from local
neuronal sources, from extrinsic CRF projections from the CeA,
or both (Veinante et al., 1997; Erb et al., 2001). To further explore
this question, we hypothesized that if β-ARs enhance BNST CRF
levels by modulating the activity of local CRF neurons, then iso-
proterenol would be expected to alter the activity of BNST neurons
that produce CRF. On the other hand, if β-AR activation resulted
in increased CRF from CeA sources, then the activity of BNST CRF
neurons might not be altered by isoproterenol. To test this hypoth-
esis, we recorded the activity of CRF-producing neurons in the
BNST in a novel CRF-reporter mouse line (Silberman et al., 2013).
To develop this line, we crossed two commercially available mouse
lines from Jackson Laboratories, the CRF-ires-cre (strain B6(Cg)-
Crhtm1(cre)Zjh/J) line and the ROSA-tomato [strain B6.Cg-
t(ROSA)26Sor< tm14(CAG-tdTomato)Hze> /J] line. Crossing
these two lines of mice resulted in offspring where a red fluorescent
protein (tomato) was targeted to cre containing neurons, which in
this case were neurons that produced cre under the control of the
endogenous Crf promoter/enhancer elements (CRF-tomato mice).
The CRF-tomato mice were found to have high levels of tomato
expression in brain areas known to be dense in CRF-producing
neurons, like the paraventricular nucleus of the hypothalamus,
the CeA, and the BNST, while brain regions that are known to
have little CRF-producing neurons, like the cortex and striatum,
were shown to have sparse tomato expression.
We then preformed whole-cell patch clamp electrophysiology
experiments on CRF-tomato neurons in the BNST. These studies
indicate that there are several different subtypes of BNST CRF
neurons based on electrophysiological characteristics. Three of
the subtypes were similar to those previous shown to exist in the
rat BNST (Hammack et al., 2007) while the two remaining sub-
types have not previously been characterized. Research is currently
ongoing in our lab to determine if distinct CRF neuronal subtypes
play dissociable roles in BNST-mediated behaviors and if they are
can be distinguished based on their projection targets or other
neurochemical markers.
Regardless of these characteristic differences in CRF neuron
subtypes, isoproterenol application resulted in a significant depo-
larization of BNST CRF neurons, an effect that was significantly
correlated with increased input resistance. These data suggest a
role of β-ARs in the direct depolarization of BNST CRF neurons
through closure of a leak or voltage-gated channel. Such a depolar-
ization could increase release of CRF from these neurons, although
this has yet to be directly tested. Together, these data suggest that
stress-induced increases in NE signaling in the BNST leads to
enhanced local CRF neuron activity in the BNST which likely leads
to enhanced CRF release. Enhanced extracellular CRF levels in the
BNST in turn leads to enhanced glutamatergic activity in the BNST
and thus increased BNST excitation (see summary Figure 1). This
enhanced level of BNST CRF may be further modulated by CRF
afferents from the CeA (Erb et al., 2001). Overall, CRF-mediated
enhancement of excitatory drive in the BNST is likely a key partic-
ipant in stress-induced reinstatement. The following section will
further describe this proposed BNST neurocircuit and its sensitiv-
ity to drug-related permutations as a critical factor precipitating
reinstatement to drug-seeking behaviors following withdrawal.
POTENTIAL ROLE OF BNST PROJECTIONS TO THE VTA IN
STRESS-INDUCED REINSTATEMENT
Although the above described studies show a clear role for
NE/CRF interactions in enhancing BNST excitability, it is not clear
how enhanced BNST excitability leads to increased drug-seeking
behavior following stress. As mentioned earlier, mesolimbic circuit
activation is a critical component of drug-seeking behavior in all
types of reinstatement models. Therefore, it is hypothesized that
BNST afferents to the VTA may be an important pathway in ini-
tiation of drug-seeking behaviors following stress. The following
sections will explore this possibility.
NEUROANATOMICAL AND FUNCTIONAL EVIDENCE FOR BNST-VTA
CIRCUITRY IN DRUG-SEEKING BEHAVIORS
A series of neuroanatomical studies showed that the BNST sends
a dense set of projections to the VTA (Georges and Aston-Jones,
2001, 2002; Dong and Swanson, 2004, 2006a,b). Disconnection of
this pathway reduces cocaine preference (Sartor and Aston-Jones,
2012) and BNST neurons projecting to the VTA become activated
during reinstatement to cocaine seeking (Mahler and Aston-Jones,
2012), suggesting BNST projections to the VTA are important
in multiple drug-related behaviors such as preference and drug
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FIGURE 1 | Model of Chronic Intermittent Ethanol-Withdrawal
Modulation of BNST CRF Circuitry. (A) Dopamine and norepinephrine
afferents synapse onto CRF-producing neurons in the BNST which in turn
influence neurotransmitter release from glutamatergic afferents onto BNST
neurons projecting to the VTA. (B) Close up view of proposed neurocircuitry
described in (A). (C,D) Model of CRF modulation of glutamatergic
transmission onto a VTA-projecting BNST neuron in a drug-naïve state (C) or
during acute ethanol withdrawal following CIE (D). Note that there are higher
levels of CRF and glutamate release during withdrawal compared to the
drug-naïve state. Figure reprinted from (Silberman et al., 2013).
seeking during reinstatement. Initial in vivo electrophysiology
studies showed that electrical and pharmacological stimulation of
the BNST can elicit increased firing of putative DA neurons in the
VTA (Georges and Aston-Jones, 2001). This pathway was further
characterized showing that antagonism of glutamatergic receptors
in the VTA can block BNST stimulation mediated enhancement
of VTA DA neuron firing while having minimal effects on puta-
tive VTA GABA neuron firing (Georges and Aston-Jones, 2002).
Together, these anatomical and electrophysiology studies suggest
that the BNST may regulate the activity of the VTA DA neurons
during reinstatement.
More recent studies using optogenetic strategies suggest that
parallel circuitry in the BNST can mediate distinct aspects of
anxiety-like behaviors (Kim et al., 2013). These studies show that
selective inactivation of cells in the region of the oval subnucleus of
the dorsal BNST (ovBNST) is correlated to a reduction in anxiety-
like behaviors and that ovBNST neurons inhibit the activity of
the anterodorsal subregion of the BNST (adBNST). These stud-
ies further show that the adBNST contains neurons that project
to the VTA, parabrachial nucleus, and lateral hypothalamus and
that selective stimulation of these pathways may promote dif-
ferent aspect of anxiolysis, as measured by increased open arm
time in an elevated plus maze and reduction in respiratory rates.
Our recent evidence further suggests that these divergent projec-
tions likely arise from distinct subpopulations of neurons in the
adBNST (Silberman et al., 2013). Kim et al. (2013) propose this
arrangement of BNST neuronal signaling may facilitate modu-
lar circuit adaptations in response to environmental stimuli by
independent tuning of divergent projection neuron populations.
Especially relevant to this review, optogenetic stimulation of adB-
NST terminals in the VTA can elicit realtime place preference,
suggesting that increased activity of certain BNST projection neu-
rons are critical for regulation of VTA-mediated reward behavior
(Jennings et al., 2013).
While the BNST contains multiple subnuclei and a variety of
neuronal cell types based on immunohistochemical and electro-
physiological characteristics (Egli and Winder, 2003; Dumont and
Williams, 2004; Hammack et al., 2007; Kash et al., 2008), stud-
ies indicate that BNST neurons that project to the VTA may be
sensitive to modulation by drugs of abuse (Dumont et al., 2008).
Interestingly, more recent work has shown that BNST neurons that
project to the VTA are more likely to become activated following a
stressor than other BNST neurons (Briand et al., 2010). Together,
these findings suggest that certain subpopulations of BNST neu-
rons, i.e., VTA-projecting neurons, are particularly important to
enhanced drug seeking following stress exposures.
CRFR1 MEDIATES ETHANOL-WITHDRAWAL-INDUCED INCREASES IN
GLUTAMATERGIC TRANSMISSION ONTO BNST NEURONS PROJECTING
TO THE VTA
In combination with previous evidence of the importance of BNST
CRF signaling to stress-induced reinstatement, we hypothesized
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that CRF modulation of BNST neurons projecting to the VTA may
be uniquely sensitive to drug-induced alterations in excitability. To
test this hypothesis we have recently performed a series of experi-
ments to determine the effect of CRF on glutamatergic transmis-
sion onto VTA-projecting BNST neurons and determine whether
chronic drug exposures can modulate this system. VTA-projecting
BNST neurons were identified by microinjecting retrograde flu-
orescent microspheres into the VTA and labeled neurons in the
BNST were recorded using whole-cell electrophysiology methods
(Silberman et al., 2013). In these studies, we showed that CRF, via
activation of CRFR1, can enhance glutamate release onto BNST
neurons projecting to the VTA. Combined with our data showing
that β-AR activation depolarizes BNST CRF neurons, the above
findings indicate that stress, via release of NE in the BNST, can
increase BNST CRF activity to, in turn, increase glutamatergic
signaling onto VTA-projecting BNST neurons (Figures 1A,B).
We then tested whether this pathway is modulated by abused
drugs by exposing VTA-retrograde tracer mice to the CIE
vapor exposure paradigm (CIE). This repeated ethanol expo-
sure/withdrawal paradigm has been shown to increase anxiety-like
behaviors during withdrawal (Kash et al., 2009) and increase
voluntary ethanol drinking post-withdrawal (Becker and Lopez,
2004), suggesting that this paradigm is an important tool in
assessing neurobiological changes in negative reinforcement path-
ways, such as the BNST, following drug exposure. Interestingly, we
found that basal glutamatergic tone was increased in excitatory
synapses that regulate VTA-projecting BNST neurons during the
acute withdrawal phase after a 2 week CIE cycle. Also, from this
enhanced basal glutamatergic tone, exogenous application of CRF
could no longer enhance glutamatergic transmission as it could
in drug-naïve or sham exposed mice. This functional occlusion of
exogenous CRF suggests that CRF receptors may already be max-
imally active during acute drug-withdrawal time points, perhaps
due to highly elevated extracellular CRF levels and sensitize BNST
CRF circuitry. This may be one reason why post-CIE CRFR1 antag-
onist injections into the BNST do not block CIE-induced increases
in ethanol self-administration (Funk et al., 2006a) and suggests
that CRFR1 antagonist treatment prior to CIE may normalize
BNST CRF circuitry during acute ethanol withdrawal. To examine
this hypothesis, we exposed a second cohort of VTA-tracer mice
to CIE with the inclusion of daily injections of a CRFR1 antago-
nist prior to ethanol vapor exposure. Pretreatment with a CRFR1
antagonist completely abolished the effects of CIE on increasing
basal glutamatergic function during acute withdrawal timepoints.
Together, these findings indicate that CIE modulates BNST CRF
neurocircuitry in vivo and that this neurocircuit becomes hyperac-
tive during CIE withdrawal (Figures 1C,D). An important caveat
to these findings is that the role of BNST CRF sensitivity has mainly
been examined during acute withdrawal phases and has pro-
vided potentially conflicting results. It will be important in future
studies to examine the mechanisms by which sensitized BNST
CRF circuitry may promote increased stress-induced drug-seeking
behavior during later time points in extended withdrawal.
Although more work will be needed to conclusively show a
role of this circuit in reinstatement behaviors, the recruitment of
the catecholamine-CRF-glutamate circuit in the BNST to drive
increased VTA activity is one promising mechanism by which
stress can enhance drug seeking in reinstatement models. Inter-
estingly, while the above described studies focused on the effect of
ethanol on BNST CRF circuitry other work indicates that cocaine
(Nobis et al., 2011) and opiates (Wang et al., 2006; Jaferi et al., 2009)
may also stimulate BNST CRF neurocircuitry in vivo. Together,
these findings suggest that modulation of BNST CRF may be
a common pathway for stress-induced reinstatement for multi-
ple classes of abused drugs. Therefore, therapeutics targeting this
system may be useful for the effective long-term prevention of
stress-induced relapse in addiction to many types of drugs.
PROPOSED MODEL OF BNST/VTA CIRCUITRY IN
STRESS-INDUCED REINSTATEMENT
The studies described above suggest a critical role of increased
activity of BNST neurons that project to the VTA in the neuro-
physiological response to stress and drug addiction. However, the
mechanism by which activation of BNST projection neurons may
modulate VTA activity is not clear.
MULTIPLE SUBTYPES OF BNST NEURONS PROJECT TO THE VTA
Some electrophysiological studies indicate that BNST projections
to the VTA are likely to be glutamatergic, as they enhance VTA
neuron firing (Georges and Aston-Jones, 2001, 2002). However,
more recent work indicates that BNST projections to the VTA
may be either glutamatergic or GABAergic (Jennings et al., 2013).
Other recent studies utilizing fluorescence in situ hybridization
and retrograde labeling techniques show that there are three
types of VTA-projecting neurons in the BNST. The vast majority
of these neurons (∼90%) are GAD+/VGlut− while other sub-
types are VGlut2+/GAD− or VGlut3+/GAD+ (Kudo et al., 2012).
This suggests that most VTA-projecting neurons in the BNST are
GABAergic, while a minority of outputs may be glutamatergic or
contain a mixture of transmitters. Our recent work shows that
VTA-projecting BNST neurons can be divided into three classes
based on electrophysiological responses to hyperpolarizing and
depolarizing current injections (Silberman et al., 2013). Although
it has yet to be tested, it is tempting to think that the differences
in GAD and VGlut2/3 expression in BNST neuron subtypes may
be related to differences in their electrophysiological firing prop-
erties. Still other studies suggest that at least some of the BNST
neurons projecting to the VTA contain CRF (Rodaros et al., 2007).
This is an important consideration as elevated CRF levels in the
VTA can drive DA neuron activity after exposure to drugs of abuse
by a number of mechanisms (Wise and Morales, 2010). Deter-
mining the contribution of these unique BNST projection neuron
subtypes to stress-induced drug-seeking behavior may be useful
in targeting future treatments for relapse prevention.
EVIDENCE FOR SUBTYPE SPECIFIC BNST INNERVATION OF VTA GABA
AND VTA DA NEURONS
Overall these findings indicate that the BNST sends a mixture
of neurotransmitters to the VTA. However, what is less clear is
whether distinct types of BNST projection neurons synapse to
different VTA neurons. Recent evidence indicates that selective
optogenetic stimulation of VTA GABA neurons disrupts reward
consumption (van Zessen et al., 2012) and increased conditioned
place aversion (Tan et al., 2012). Furthermore, selective opto-
genetic stimulation of VTA DA neurons can enhance positive
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reinforcing actions in an operant food seeking task and can reacti-
vate previously extinguished food seeking behavior in the absence
of cues (Adamantidis et al., 2011). Interestingly, recent immu-
noelectron microscopy work indicates that vGLUT containing
BNST projection neurons may selective target VTA DA neurons
while GABAergic BNST projection neurons may specifically target
GABA neurons in the VTA [(Kudo et al., 2012) although see also
(Jennings et al., 2013)]. Together, these findings may indicate that
enhanced activity of BNST projections to the VTA during rein-
statement may stimulate VTA DA neurons via increasing local
glutamatergic levels while at the same time disinhibiting VTA
DA neuron firing by inhibiting local GABA release (see model,
Figure 2). This may be one mechanism by which drug-withdrawal
enhances burst firing of VTA DA neurons (Hopf et al., 2007),
an effect that is important in drug-seeking behaviors (Wanat
et al., 2009), and may be especially important in stress-induced
reinstatement models.
The precise role of distinct VTA-projecting BNST neurons in
reinstatement is not yet fully understood. For instance, although
evidence suggests that BNST neurons that project to the VTA
can be mainly GABAergic, but also glutamatergic or potentially
both (Kudo et al., 2012), it is not clear if these pathways have
an equal distribution of synaptic strength. Furthermore, some
BNST projections to the VTA may contain CRF (Rodaros et al.,
FIGURE 2 | Summary Model of Reinstatement Related BNST andVTA
Connectivity. CRF+ neurons modulate the activity of VTA-projecting BNST
neurons. Evidence (Kudo et al., 2012) shows that at least three types of
VTA-projecting neurons are located in the BNST: (1) a GABAergic projection
(∼90% of all BNST projection neurons) that selectively innervates VTA
GABA neurons to provide disinhibition of VTA DA neurons; (2) a
glutamatergic (Glut) projection that selectively targets VTA DA neurons; and
(3) a mixed GABA/Glut projection that also targets VTA DA neurons. These
projection neuron populations may exist in both the dorsal and ventral
BNST subregions (d and vBNST, respectively) and each projection pathway
may have distinct and coordinated responses to chronic drug exposure,
withdrawal, and reinstatement. Coordinated activity of dBNST and vBNST
projection neurons is likely regulated by dBNST interneurons, of which
CRF+ neurons may be a critical component. This local CRF neuron
coordination of BNST activity might also be altered by chronic exposure and
withdrawal and may be an important target for the prevention of
relapse-like behaviors.
2007) but it is not clear which of the VTA-projecting neurons
described by Kudo et al. or Jennings and Sparta et al. are also CRF
positive. If so, this may suggest that a single population of VTA-
projecting BNST neurons may have divergent modes of action in
reinstatement related behaviors based on which neurotransmitter
is released at specific time points relative to reinstatement trigger
exposure. Lastly, most of the electrophysiology studies described
in this review focused on neurocircuitry in the dorsal subregion
of the BNST while most of the behavioral work has focused on
activity of the ventral BNST subregion. This is an important
consideration as the dorsal BNST, which has a high proportion
of GABAergic interneurons, sends afferents to the ventral BNST,
which has a higher proportion of projection neurons (Dong et al.,
2001). This suggests that the dorsal BNST might coordinate overall
BNST output via modulation of ventral BNST projection neu-
rons, potentially via BNST CRF interneuron activity. It is not yet
clear if interneurons or VTA-projecting neurons from the dorsal
and ventral BNST are equally mutable to chronic drug expo-
sures/withdrawal cycles. While more conclusive research will be
needed to test these intriguing possibilities, these findings may
indicate dissociable roles of BNST projection neuron subtypes
in mediating various aspects of drug-seeking behavior during
reinstatement that could potentially be targeted individually for
pharmacotherapies for relapse prevention in the future.
POTENTIAL ROLE OF BNST CRF SIGNALING IN CUE-INDUCED
REINSTATEMENT
EVIDENCE FOR DIRECT AND INDIRECT DOPAMINERGIC ACTIVATION OF
BNST IN CUE-INDUCED REINSTATEMENT
In addition to its role in stress-induced reinstatement described
above, recent evidence may suggest that BNST CRF neurocircuitry
could also play a role in cue-induced reinstatement. BLA DA recep-
tor activation is critical for cue-induced reinstatement (See et al.,
2001) and DA can increase BLA activity, but only after chronic
drug exposure (Li et al., 2011). Since the BLA sends direct projec-
tions to the BNST as well as via indirect projections through the
CeA (Davis et al., 2010), DA induced activation of the BLA may
enhance BNST excitability to precipitate reinstatement following
a cue exposure. In addition, drugs of abuse and other reward-
ing stimuli can also directly increase extracellular DA levels in the
BNST (Carboni et al., 2000; Park et al., 2012). Previous work in
our lab shows that DA can enhance glutamate release in the BNST
via activation of CRFR1 (Kash et al., 2008). This effect is fur-
ther confirmed by our more recent work indicating that DA can
depolarize BNST CRF neurons (Silberman et al., 2013). Together,
these findings suggest both direct and indirect mechanisms for
DA induced increases in BNST excitability and point to a poten-
tial role of BNST DA circuitry in cue-induced reinstatement via
modulation of BNST CRF circuitry.
Importantly, behavioral evidence also shows a potential role
for the BNST in cue-induced reinstatement models. For instance,
recent findings indicate that pharmacological inactivation of the
BNST can reduce cue-induced reinstatement (Buffalari and See,
2011). In addition, much like earlier studies showing selective
increases in c-fos in VTA-projecting BNST neurons following
stress-induced reinstatement, recent findings show that increased
c-fos activation in VTA-projecting BNST neurons is correlated
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to enhanced cocaine-seeking following an exposure to a drug-
associated cue (Mahler and Aston-Jones, 2012). Together with our
electrophysiology data, these findings suggest that DA may increase
extracellular CRF levels in the BNST via enhancing the activity of
local BNST CRF neurons,which in turn increases glutamate release
onto VTA-projecting BNST neurons, leading to increased VTA DA
firing to reinstate drug-seeking behaviors.
EVIDENCE FOR CONVERGENCE OF CUE-INDUCED AND
STRESS-INDUCED REINSTATEMENT PATHWAYS IN THE BNST
Interestingly, while clinical evidence shows that exposing recover-
ing addicts to drug-associated cues results in enhanced feelings of
craving, recent findings indicate that these same cues also increase
feelings of negative affect (Fox et al., 2007). Therefore, drug-
associated cues could act as a psychological stress by activating
stress-related neurocircuitry. This suggests that drug-associated
cues may concurrently increase both DA and NE signaling in these
patients. Our data suggest that DA and NE can additively enhance
BNST excitability (Nobis et al., 2011), suggesting a convergence of
cue-induced (dopaminergic) and stress-induced (noradrenergic)
reinstatement pathway influences on BNST excitability. Preclin-
ical studies also suggest a link between cue and stress-induced
reinstatement (Buffalari and See, 2009) suggesting that simultane-
ous exposure to drug-cues and stress can greatly increase the risk
of relapse in recovering addicts. Together, these findings indicate
that BNST CRF signaling is an important potential target for con-
vergent influences of both cue and stress-induced reinstatement
pathways.
SUMMARY AND POTENTIAL TREATMENTS
The findings reviewed here suggest that a catecholamine-CRF-
glutamatergic signaling pathway in the BNST plays an important
role in the reinstatement to drug-seeking behavior, an impor-
tant animal model of relapse to alcohol/drug addiction. While
this pathway is clearly important in stress-related behaviors, espe-
cially in stress-induced reinstatement, further studies suggests that
this pathway may also be important in cue-induced reinstate-
ment. Therefore, pharmacotherapies targeting this pathway may
be useful in the prevention of relapse to both drug-associated
cues and stressors. Unfortunately, relapse can be a life-long strug-
gle in recovering addicts, which means that pharmacotherapies to
prevent relapse likely need to be taken daily for extended peri-
ods of time. Therefore these therapies need to be well-tolerated
and devoid of harsh side-effects. As described earlier, agonist
therapies targeting the DA aspect of this pathway may be prob-
lematic from the side-effect standpoint due to effects on the
cardiovascular system and abuse liability. DA antagonist thera-
pies are also problematic for their potential for extra-pyramidal
(Peacock et al., 1999) and anhedonic side effects (Stein, 2008).
Recent studies have looked into the effect of β-AR antagonists to
reduce the probability of relapse in the clinical population (Hughes
et al., 2000; Kampman et al., 2001; Schwabe et al., 2011). Overall,
these studies have shown β-AR antagonist to potentially be use-
ful in the clinical setting, especially for reducing stress-induced
changes in habitual behaviors and in those patients that have
more severe withdrawal symptoms. However, it is unclear if treat-
ment with β-AR antagonists would have an effect on cue-induced
relapse.
Since DA and β-AR activation enhances BNST activity via
CRFR1 activation, then CRFR1 antagonists might be a better alter-
native for the effective long-term prevention of both cue and
stress-induced relapse. CRFR1 antagonists have been shown to
reduce ethanol intake following withdrawal in a number of pre-
clinical studies (Funk et al., 2007; Logrip et al., 2011). To date,
there have been no studies examining the effectiveness of CRFR1
antagonists in relapse prevention in the clinical setting. However,
this class of drugs has been studied in the clinical setting to treat
anxiety disorders and other stress-related disorders. While these
studies have shown limited effectiveness of CRFR1 antagonists
in treating general anxiety disorder (Coric et al., 2010) or irri-
table bowel syndrome (Sweetser et al., 2009), these compounds
can produce significant signal reductions in the amygdala during
pain expectation in humans (Hubbard et al., 2011). These find-
ings suggest that CRFR1 antagonists may be useful in reducing
negative affect in response to specific psychological stimuli. Impor-
tantly, these drugs are very well tolerated in the above mentioned
studies and have been shown to cause no significant side-effects
(Kunzel et al., 2003; Schmidt et al., 2010). However, to date many
CRF antagonists have been shown to have undesirable lipophilic
or pharmacokinetic profiles limiting their bioavailability and effi-
cacy in clinical trials (Zorrilla and Koob, 2010). CRF antagonists
with better pharmacokinetics may prove useful in the treatment
of addiction in the future through interference with the proposed
BNST CRF reinstatement circuit described here. Overall, CRF cir-
cuitry within the BNST is a critical locus for interactions between
stress and reward signaling in addiction and may be an important
target requiring further study for the treatment of relapse and
addiction.
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